Clinical Research News

May 2022

NMR* spectroscopy is playing a key role in our growing understanding of the long-term systemic effects of SARS-CoV-2 infection, using molecular phenomics. The different studies reveals the potential of metabolomic phenotyping in risk screening or organ dysfunction after acute COVID disease

COVID-19 patient stratification and post-treatment monitoring: NMR role

Although SARSCoV2, the virus that causes COVID19, is primarily a respiratory virus, the disease seems to cause also neurologic, renal, hepatic, and vascular damage. Researchers from the Universit├Ąt zu L├╝beck in Germany used NMR* to explore the specificity of metabolic profiles in patients with COVID19, showing a number of consistent changes associated with disturbing energy status, hepatic damage, and dyslipidemia.

The potential of NMR for risk assessment and long-term monitoring of long COVID-19

Long COVID19 is looming and we need accurate, quantitative analysis to serve this growing patient population. NMR*-based metabolomics approach and established integrated cross-population biomarkers for acute-phase SARS-CoV-2 infection help us understand how metabolic phenotypes influence disease risk not only in individuals but also in entire populations.

*Research use only. Bruker NMR instruments are not intended for use in clinical diagnostic procedures.